C

ancer patients across the country are increasingly being tested for “microsatellite instability,” or MSI status — characterized by a set of genetic markers that can help doctors identify the most effective treatment.

In this boom, Dr. Patrick Soon-Shiong has spotted a business opportunity.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.